Saturday, November 2, 2024
HomeTagsGPC3

GPC3

Cytovia Therapeutics Presents New Preclinical Data for Its GPC3 Flex-NK™ Cell Engager Antibody in Combination

Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell engineering and multispecific antibodies, announced today that...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics